The present application relates to cardenolide and bufadienolide derivatives of formula (I), wherein R15= -C(O)-NR17R18, wherein R17 and R18 are joined together with any intervening atoms to form an optionally substituted heterocycloalkyl ring, as well as pharmaceutical compositions thereof and these compounds of formula (I) for use in the treatment of cancer.